Jefferson to test British company's augmented intelligence technology

The AI technology Jefferson is evaluating is designed to manage the care of pregnant women with gestational diabetes in their homes.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.